Doping-French laboratory suspended from anti-doping activities
Send a link to a friend
[November 04, 2017]
(Reuters) - France's main
anti-doping laboratory, already under a provisional ban, has been
suspended from carrying out anti-doping activities for up to six
months because of analytical issues, the World Anti-Doping Agency
(WADA) said on Friday.
The new suspension, which took effect on Oct 31, prohibits the
Chatenay-Malabry laboratory from all analyses of urine and blood
samples, WADA said in a statement.
During the suspension, samples that have not yet been analyzed by
the Paris laboratory, samples currently undergoing a confirmation
procedure and any samples for which an adverse analytical finding
has been reported must be securely transported to another
WADA-accredited laboratory.
The laboratory was provisionally suspended on Sept 24 due to issues
self-reported to WADA by the laboratory.
Since then disciplinary proceedings were carried out by an
independent disciplinary committee, which made a recommendation on
the status of the laboratory's accreditation to the WADA Executive
Committee chair.
The laboratory, where disgraced American cyclist Lance Armstrong's
samples were tested, may appeal this decision to the Court of
Arbitration for Sport (CAS) within 21 days of receipt of notice.
[to top of second column] |
A woman walks into the head office for the World Anti-Doping Agency
(WADA) in Montreal, Quebec, Canada on November 9, 2015.
REUTERS/Christinne Muschi/File Photo Picture Supplied by Action
If the laboratory addresses all non-conformities identified by the
Laboratory Expert Group or WADA, it may apply for reinstatement
prior to the expiry of the six month suspension period.
Should the laboratory not address the non-conformities by the end of
the six-month suspension period, WADA may extend the suspension of
the laboratory’s accreditation for an additional six months, WADA
said.
(Reporting by Gene Cherry in Salvo, North Carolina, editing by Nick
Mulvenney)
[© 2017 Thomson Reuters. All rights
reserved.] Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|